MICHAEL BIGHAM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL BIGHAM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL BIGHAM. MICHAEL BIGHAM is a Director in XENOGEN CORP ($XGEN) and a Chairman and CEO in Paratek Pharmaceuticals, Inc. ($PRTK) and a Director in Paratek Pharmaceuticals, Inc. ($PRTK) and a Exec. Chairman of the Board in Paratek Pharmaceuticals, Inc. ($PRTK) and a Director in Adamas Pharmaceuticals Inc ($ADMS).
Address: ABINGWORTH MNGMNT INC. 3000 SAND HILL RD, BLDG 4, STE 135 MENLO PARK 94025 CA
Companies in which MICHAEL BIGHAM is an Insider
Adamas Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL BIGHAM: Director
Holdings: 10,000 shares
Current Value: $161,600
Latest Transaction: Jun 04 2021
$ADMS Market Capitalization: $364.02M
$ADMS Previous Close: $16.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Paratek Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL BIGHAM: Exec. Chairman of the Board, Director, Chairman and CEO
Holdings: 827,767 shares
Current Value: $12,623,447
Latest Transaction: Apr 01 2021
$PRTK Market Capitalization: $346.19M
$PRTK Previous Close: $15.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
XENOGEN CORP
Industry: MEASURING & CONTROLLING DEVICES, NEC [3829]
Position of MICHAEL BIGHAM: Director
Holdings: 515,464 shares
Current Value: $0
Latest Transaction: Aug 15 2005
$XGEN Market Capitalization: $60892.00
$XGEN Previous Close: $0.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MICHAEL BIGHAM
Sentiment: All, ADMS, PRTK, XGEN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Option Exercise | A | 5.21 | 10,000 | 52,100 | 10,000 | |
| Jun 04 2021 | ADMS | Adamas Pharmaceuti ... | BIGHAM MICHAEL | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| Apr 01 2021 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Grant | A | 0.00 | 281,250 | 0 | 827,767 | 546.5 K to 827.8 K (+51.46 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Sell | S | 6.71 | 26,063 | 174,883 | 546,517 | 572.6 K to 546.5 K (-4.55 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Sell | S | 6.95 | 18,337 | 127,442 | 572,580 | 590.9 K to 572.6 K (-3.10 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Sell | S | 5.93 | 26,250 | 155,663 | 590,917 | 617.2 K to 590.9 K (-4.25 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | BIGHAM MICHAEL | Exec. Chairman of t ... | Grant | A | 0.00 | 75,000 | 0 | 617,167 | 542.2 K to 617.2 K (+13.83 %) |